Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated May 1, 2018 (8 years ago)

Ampicillin and Sulbactam for Injection (Ampicillin Sodium and Sulbactam Sodium)

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.

Cause type: Particulate / foreign matter

Visible foreign particles - glass, metal, fibers or other material - found in the product. Particles can enter from equipment wear, containers or the process, and are dangerous in injectables. All particulate / foreign matter recalls.

What was recalled

Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ, NDC 55150-117-20.

Affected NDC 55150-0117-20

Compare with the code on your package — it is the most precise check available.

Drug: Ampicillin

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Ampicillin and Sulbactam
Ampicillin Sodium and Sulbactam Sodium
NDC 55150-0117
AMPICILLIN SODIUM 2 g/1; SULBACTAM SODIUM 1 g/1 Injection, Powder, for Solution
Intramuscular|intravenous
Eugia US LLC Rx
Recalling firm
AuroMedics Pharma LLC
NDC code
55150-117-20
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0866-2018 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Ampicillin recalls

See all

Other recalls by AuroMedics Pharma LLC

All 2018 recalls
Class II · Moderate risk

Acyclovir Sodium Injection

Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.

Completed Particulate / foreign matter AuroMedics Pharma LLC NDC 55150-154-10 D-0013-2023